523 263

Cited 0 times in

새로운 항정신병약물 : 세로토닌 및 글루타메이트 수용체 관련 약물들

Other Titles
 Newer Antipsychotics : Serotonin and Glutamate Receptor Related Drugs 
Authors
 김찬형 
Citation
 Korean Journal of Psychopharmacology (대한정신약물학회지), Vol.12(2) : 115-123, 2001 
Journal Title
 Korean Journal of Psychopharmacology (대한정신약물학회지) 
ISSN
 1017-5717 
Issue Date
2001
Keywords
Schizophrenia ; Serotonin ; Glutamate
Abstract
Several decades of research attempting to explain schizophrenia regarding dopamine hyperactivity hypothesis have produced disappointing results. New hypotheses focusing on serotonin-dopamine interactions and hypofunction of the NMDA glutamate transmitter system have been emerging as potentially more promising concepts. The next generation of treatments for schizophrenia, whether they are based on dopamine, serotonin, or glutamate etc., should be effective on negative symptoms and cognitive deficits as well as positive symptoms. In this article, I review the brief overview of these hypotheses and new drugs based on the hypotheses.
Files in This Item:
T200102944.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Psychiatry (정신과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Chan Hyung(김찬형)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/142759
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links